Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,175.1
-7.8 (-0.25%)

 

  • STI Straits Times Index
    3,175.1
    -7.8 (-0.25%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,495.8
    4.5 (0.30%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,204.7
    -221.9 (-0.84%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,466.5
    -10.7 (-0.31%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    27,728.1
    144.0 (0.52%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,205.4
    46.4 (0.75%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,021.9M
  • Value: 1,264.6M
  • Rise: 145
  • Fall: 202
  • Unch: 412

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
SinoCloud0.001-
Sembcorp Marine0.120-0.003
YZJ Shipbldg SGD1.440+0.010
Mercurius0.053-0.003
CPH0.005-0.002
ThaiBev0.670+0.005
Kim Heng0.100-0.003
Intl Cement0.025-0.002
SPH1.900-0.020
AMOS0.011-0.001

World Indices

World Indices
Name Last Change
Nasdaq 14,895.1 +114.6
HSI 26,204.7
HSCEI 9,296.4
Jakarta 6,205.4
Nikkei 225 27,728.1
SSE Comp 3,466.5
Shanghai A 3,633.2
Shanghai B 260.1
KOSPI 3,276.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

23ANDME HOLDING CO 23ANDME HOLDING CO CLASS A
Updated on 04 Aug 2021 (End of trading day)
Last (USD): 8.650 Change: -0.030 High: 9.060 Remarks: -
Change (%): -0.35 Low: 8.630
Open 8.680 Yesterday's Close 8.68
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 2,398,580 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.11959 Trailing EPS (USD) e -0.11959 NAV (USD) b 1.0950
PE a - Trailing PE f - Price / NAV b 7.8995
Dividend (USD) d - Cash In Hand (USD) g 0.0002 Issued & Paid-up Shares c 92,672,500
Dividend Yield (%) d - Price / Cash In Hand g 43,250.000 Treasury Shares h -
Market Cap (M) 3,515.632 Enterprise Value (M) 3,515.551
Piotroski F Score - Exchange Code ME Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 89.6
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 09 Jul 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 17 Jun 2021.

Peer Comparison

<
Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference 23ANDME HOLDING CO NASDAQ 3,515.632 - - 7.8995 -
Industry Biotechnology NASDAQ 3,134.194 106.306 106.381 7.5868 0.535
Local Peer MODERNA INC NASDAQ 168,260.308 - 281.294 43.8406 -
Local Peer AMGEN INC NASDAQ 131,176.424 18.058 24.835 - 2.821
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 100,095.963 5,777.778 68.866 33.8015 -
Local Peer GILEAD SCIENCES INC NASDAQ 86,826.960 705.882 16.820 4.4052 3.928
Local Peer ILLUMINA INC NASDAQ 73,671.600 112.304 116.939 14.9678 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 61,896.719 17.618 15.459 5.1680 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 51,779.235 19.095 25.998 5.6304 -
Local Peer BIOGEN INC NASDAQ 50,388.057 12.595 26.270 4.6864 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 31,807.737 - - 7.9446 -
Local Peer SEAGEN INC NASDAQ 29,693.448 48.387 49.716 8.7559 -
Local Peer ALNYLAM PHARMACEUTICALS INC NASDAQ 21,562.455 - - - -
Local Peer 10X GENOMICS INC NASDAQ 20,293.107 - - 26.9692 -
Other Local Peers BIO-TECHNE CORP (NASDAQ), EXACT SCIENCES CORP (NASDAQ), INCYTE CORPORATION (NASDAQ), NOVAVAX INC (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), RECURSION PHARMACEUTICALS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), ARVINAS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ALKERMES PLC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), KODIAK SCIENCES INC (NASDAQ), OLINK HLDG AB SPON ADS EACH REP 1 ORD SHS (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), LYELL IMMUNOPHARMA INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), INSMED INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), ALECTOR INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), INSTIL BIO INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), SEER INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), CORTEXYME INC (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), ORGANOGENESIS HOLDINGS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), XENCOR INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), MACROGENICS INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), MAXCYTE INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), VALNEVA SE SPON ADS EACH REPR 2 ORD SHS (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), MONTE ROSA THERAPEUTICS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), UNIQURE N.V. (NASDAQ), JANUX THERAPEUTICS INC (NASDAQ), OCUGEN INC (NASDAQ), REGENXBIO INC (NASDAQ), BIOATLA INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), ALLOVIR INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), AGENUS INC (NASDAQ), FIBROGEN INC (NASDAQ), GRAPHITE BIO INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), NUVALENT INC (NASDAQ), VAXCYTE INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), IMMUNOGEN INC (NASDAQ), NKARTA INC (NASDAQ), PRECIGEN INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), INHIBRX INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), CARIBOU BIOSCIENCES INC (NASDAQ), VAXART INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), HUMANIGEN INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), NAUTILUS BIOTECHNOLOGY INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), OMEROS CORP (NASDAQ), IVERIC BIO INC (NASDAQ), PERSONALIS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), EDGEWISE THERAPEUTICS INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), AFFIMED N V (NASDAQ), IMAGO BIOSCIENCES INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), KADMON HLDGS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), OMEGA THERAPEUTICS INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), IMMATICS N V (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), MERUS B V (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), IMMUNOVANT INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), SESEN BIO INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), EPIZYME INC (NASDAQ), CURIS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), MOLECULAR PARTNERS AG SPON ADS EACH REP 1 ORD SHS (NASDAQ), PASSAGE BIO INC (NASDAQ), AKOYA BIOSCIENCES INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), RANI THERAPEUTICS HLDGS INC (NASDAQ), COMPUGEN (NASDAQ), CHIMERIX INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), VERASTEM INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), XBIOTECH INC (NASDAQ), VOR BIOPHARMA INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), RAIN THERAPEUTICS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), AKOUOS INC (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), ATHIRA PHARMA INC (NASDAQ), ALTIMMUNE INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), VERA THERAPEUTICS INC. (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), IKENA ONCOLOGY INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), ATHERSYS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), ONCORUS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), AVROBIO INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), BIOVIE INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), AEROVATE THERAPEUTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), CHIASMA INC (NASDAQ), INMUNE BIO INC (NASDAQ), KAMADA LTD (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), ADICET BIO INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), MIROMATRIX MEDICAL INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), ATRECA INC (NASDAQ), TREVENA INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), NEXTCURE INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ELEVATION ONCOLOGY INC (NASDAQ), IN8BIO INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), IMMUNOME INC (NASDAQ), HCW BIOLOGICS INC (NASDAQ), MEDICINOVA INC (NASDAQ), CHEMOMAB THERAPEUTICS LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), MARKER THERAPEUTICS INC (NASDAQ), GEMINI THERAPEUTIC (NASDAQ), EQUILLIUM INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), ARDELYX INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), CONTRAFECT CORP (NASDAQ), SYNLOGIC INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), LAVA THERAPEUTICS NV (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), SAVARA INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), AXCELLA HEALTH INC (NASDAQ), ORGENESIS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), EVOGENE LTD (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), CYTOCOM INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), IMV INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), INFLARX N V (NASDAQ), LONGEVERON INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), BON NAT LIFE LTD (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), GLYCOMIMETICS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), ENSYSCE BIOSCIENCES INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), OTONOMY INC (NASDAQ), GAIN THERAPEUTICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), ARAVIVE INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), BRIACELL THERAPEUTICS CORP (NASDAQ), METACRINE INC (NASDAQ), COHBAR INC (NASDAQ), ATYR PHARMA INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), PRECIPIO INC (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), VACCINEX INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ADVAXIS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), BIOCARDIA INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), ALTAMIRA THERAPEUTICS LTD (NASDAQ), SOLIGENIX INC (NASDAQ), TRANSCODE THERAPEUTICS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), HISTOGEN INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), ADITX INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), ZIVO BIOSCIENCE INC (NASDAQ), PALISADE BIO INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), GEOVAX LABS INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SENESTECH INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ)
Global Peer AMGEN-T HKEx 1,011,789.594 17.959 24.707 - 2.837
Global Peer CSL LTD ASX 133,712.349 42.634 35.134 12.6533 0.999
Global Peer WUXI BIO